![](http://static.aminer.org/default/default.jpg)
Rückert Michael
Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO)
Department of Cardiothoracic, Transplantation, and Vascular Surgery (HTTG), Hannover Medical School, Carl-Neuberg-Straβe 1, 30625 Hannover, Germany;REBIRTH-Cluster of Excellence, Hannover Medical School;Hannover Medical School, Hannover Medical School
Follow
Claim
分享
Follow
Claim
分享
基本信息
views: 13
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
No content for now
Research Interests
Papers共 35 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
C. M. Reichardt, M. Muñoz-Becerra,A. Rius Rigau,M. Rückert,R. Fietkau,G. Schett,U. S. Gaipl,B. Frey,L. E. Muñoz
Maike Y Adler, Insaf Issoual,Michael Rückert,Lisa Deloch,Carola Meier,Thomas Tschernig, Christoph Alexiou,Felix Pfister,Anja FRM Ramsperger,Christian Laforsch,Udo Gaipl, Katharina Jüngert,
STRAHLENTHERAPIE UND ONKOLOGIE (2023): S167-S167
Cited0Views0Bibtex
0
0
Frontiers in Oncology (2023): 981239
Lisa Deloch, Antonia Voellings,Thomas Weissmann,Michael Ruckert,Rainer Fietkau,Benjamin Frey,Udo Gaipl
STRAHLENTHERAPIE UND ONKOLOGIE (2023): S162-S162
Cited0Views0Bibtex
0
0
Strahlentherapie und Onkologieno. 12 (2023): 1164-1172
STRAHLENTHERAPIE UND ONKOLOGIE (2023): S36-S36
Cited0Views0Bibtex
0
0
Springer Reference Medizin Kompendium Internistische Onkologiepp.1-20, (2023)
Radiotherapy and Oncology (2023): S330-S330
International review of cell and molecular biology (2023): 239-277
Load More
Author Statistics
#Papers: 33
#Citation: 667
H-Index: 10
G-Index: 17
Sociability: 5
Diversity: 2
Activity: 23
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn